Healthcare Analytics

CareView Communications Executes Agreement with Baltimore VA Medical Center Under Agreement with Decisive Point Consulting Group, LLC

CareView Communications Executes

CareView Communications, Inc., a leading provider of integrated virtual care solutions for the healthcare industry announced the signing of an agreement with Baltimore VA Medical Center under its partnership with Decisive Point Consulting Group to deploy its advanced predictive patient monitoring system. Decisive Point Consulting Group, LLC, a Small Business Administration Certified Service Disabled Veteran Owned Small Business (SDVOSB), contracts directly with VA hospitals to use a variety of CareView products to enhance the services being provided to veterans.

CareView's predictive patient monitoring system leverages state-of-the-art technology, including AI and machine learning, to proactively predict inpatient falls and empower healthcare providers with real-time insights. By using intelligent predictive monitoring, medical staff can proactively address patients at risk, prevent potential accidents, and subsequently reduce costs associated with patient falls while elevating the standard of patient care.

A distinctive feature of CareView's platform is creating a serene care environment ideal for VA hospitals by having no audible alarms within patient areas. Patient privacy remains paramount, further fortified by the platform's privacy option, which enhances security and offers peace of mind to patients and their families.

"At CareView, we are dedicated to redefining patient care through innovation," stated Sandra McRee, Chief Operating Officer at CareView. "Our collaboration with the Baltimore VA Medical Center signifies a significant leap towards realizing this vision and ensuring the well-being of our nation's veterans."

The Baltimore VA Medical Center has eagerly embraced this collaboration, showcasing their strong commitment to implementing innovative solutions that elevate patient safety and the quality of care. This partnership with CareView perfectly aligns with their mission and steadfast dedication to providing the highest standard of care for veterans.

Furthermore, this partnership harmoniously aligns with CareView's steadfast commitment to advancing virtual care solutions. These solutions are designed to elevate patient outcomes, streamline clinical workflows, prioritize patient safety, and drive notable cost efficiencies. By thoughtfully integrating technology, CareView aims to significantly contribute to fostering a safer healthcare environment for both patients and healthcare providers.

About CareView Communications, Inc.

For over a decade, CareView has been dedicated to supporting hospital care teams with its innovative virtual care solutions. The Company has established successful partnerships with over 200 hospitals nationwide, implementing effective inpatient virtual care strategies that greatly enhance patient safety and overcome critical staffing challenges. The CareView platform, fueled by industry-leading predictive technology and supported by its purpose-built hardware, specifically addresses the unique requirements of virtual nursing and virtual sitting use cases. The CareView team works closely with their hospital partners to understand their evolving needs and deliver tailored virtual care strategies that align with their objectives. By providing healthcare professionals with the tools they need to deliver exceptional care, CareView contributes to improved patient outcomes and a more sustainable healthcare ecosystem.

Spotlight

Spotlight

Related News

Health Technology

Emory Healthcare Teams Up with DrFirst to Enhance Medication Adherence

Emory Healthcare | November 06, 2023

Emory Healthcare aims to improve prescription affordability and medication outcomes by offering comprehensive, real-time data, including patient out-of-pocket drug costs. Emory is optimizing clinician workflows and enhancing patient medication adherence with Fuzion through DrFirst's three medication management services. UPMC Health System employs AI-driven virtual assistants to address medication nonadherence, engaging high-risk patients via SMS or robocall messages before and between prescription fills. Emory Healthcare and DrFirst have collaborated to address medication adherence by providing comprehensive data at the point of care, including options for patients to assess out-of-pocket drug costs. Emory aims to aid patients in achieving prescription affordability and enhancing their medication outcomes. Emory Healthcare has implemented three medication management services available within the Fuzion platform by DrFirst, which offer clinicians access to medication histories. This initiative aims to streamline clinician workflows and enhance medication adherence among patients. This development holds importance in its potential to decrease adverse drug events for Emory Healthcare patients and provide them with AI-driven information about prescription costs during medical visits, thereby fostering transparency and informed decision-making. DrFirst's advanced medication management platform can enhance electronic prescribing workflows by optimizing the usability of clinical data. This platform is capable of electronically completing prior authorizations and addressing claim rejections. Furthermore, it provides real-time prescription drug benefits and pricing information, enabling physicians to discuss medication costs with their patients and potentially transition to more cost-effective therapeutic alternatives. This can reduce prescription abandonment rates and, consequently, enhance overall health outcomes. G. Cameron Deemer, CEO of DrFirst, said. For many patients, especially those with chronic conditions, taking their medications as prescribed is vital to positive health outcomes and staying out of the hospital. [Source – Healthcare IT News] DrFirst believes that precise and comprehensive medication data contributes significantly to patient safety. Additionally, presenting an entire year's worth of patient medication history can expedite medication reconciliation procedures for healthcare providers. Furthermore, providing drug-allergy, dosing, and duplicate therapy alerts directly to clinicians at the point of care supplies them with valuable information. The integration of technology aids in rendering clinical data more user-friendly and facilitates smoother workflows, ultimately aiding clinicians and patients in achieving improved medication outcomes. Emory Healthcare is set to implement HIPAA-compliant automated patient messaging for electronic prescription alerts. This system will allow patients to review their prescriptions and receive relevant patient education materials, among other features. As for the broader trend, the adoption of AI for improving medication adherence has demonstrated its effectiveness, leading to positive outcomes in both clinical and financial aspects.

Read More

Health Technology, Digital Healthcare

Johnson and Johnson Embraces New Era with Enhanced Visual Identity

Johnson and Johnson | September 15, 2023

Johnson and Johnson's brand identity communicates the company's bold healthcare innovation while staying true to its global patient care. Leveraging advanced medicine and technology, the company proactively tackles complex diseases with more innovative, less invasive, and personalized solutions. The company plans to gradually implement the new logo, colors, and font across all its materials, product packaging, and branding assets. Johnson and Johnson is currently revitalizing its brand and consolidating its MedTech and pharmaceutical segments under the unified name of Johnson and Johnson, demonstrating a steadfast commitment to healthcare innovation and addressing the most challenging health issues. The announcement signifies a pivotal moment in Johnson and Johnson's evolution as the company harnesses its extensive knowledge of innovative medicine and cutting-edge medical technology. This strategic move aims to proactively address, treat, and ultimately find cures for intricate diseases while simultaneously ushering in solutions characterized by heightened intelligence, reduced invasiveness, and greater personalization, marking a significant stride toward reshaping the future of healthcare. The company's two major segments will become more closely associated with the Johnson and Johnson brand. Over time, Janssen, the company's pharmaceutical part, will assume the name Johnson and Johnson Innovative Medicine, while the medical technology segment will retain the Johnson and Johnson MedTech designation. The pharmaceuticals segment leads the way in advancing healthcare, pioneering treatments to reshape the future of well-being. Johnson and Johnson Innovative Medicine combines a compassionate scientific approach to effectively confront the most complex diseases in oncology, immunology, neuroscience, cardiovascular, pulmonary hypertension, and retina to develop future medications. Simultaneously, the medical technology segment dedicates itself to addressing the most pressing healthcare challenges through innovations at the nexus of biology and technology. Vanessa Broadhurst, Executive Vice President of Global Corporate Affairs, stated, Our Johnson and Johnson brand identity communicates our bold approach to innovation in healthcare while staying true to the care we have for our patients around the world. [Source: Business Wire] The updated Johnson and Johnson logo, featuring letters drawn in a single stroke for added contrast and a sense of unexpectedness, embraces both long and short versions, with the 'J&J' abbreviation gaining prominence, especially in digital contexts. The color palette leans toward a refreshed and contemporary red, symbolizing the company's agility in responding to health challenges and evolving with the times. The revamped ampersand now signifies global recognition, openness, and the connections that breathe life into the brand's purpose. In terms of art direction, elements such as illustration and photography have undergone careful curation to evoke energy, optimism, and inclusivity, presenting a distinctive approach within the healthcare domain.

Read More

Health Technology

GE HealthCare Rolls Out Vscan Air SL Ultrasound Device

GE HealthCare | September 06, 2023

GE HealthCare's latest release is poised to empower healthcare professionals with advanced diagnostic capabilities. Vscan Air SL aims to aid physicians in expediting the identification and treatment of illnesses. This portable, wireless ultrasound imaging device will revolutionize cardiac assessments, seamlessly integrating with diverse ultrasound technologies to enhance GE HealthCare's medical equipment. GE HealthCare has introduced Vscan Air SL, a state-of-the-art medical instrument engineered to enhance the efficiency of healthcare practitioners in diagnosing and treating diverse medical conditions. Due to its portability and wireless functionality, this device excels at conducting cardiac and vascular assessments directly at the patient's bedside. It leverages single-crystal transducer technology, setting a new standard for ultrasound imaging precision. By integrating GE HealthCare's SignalMax and XDclear innovations, Vscan Air SL ensures unparalleled image quality and diagnostic accuracy. This instrument aims to provide remarkable penetration levels, image clarity, and sensitivity, delivering a diagnostic experience of the utmost reliability. Vscan Air SL facilitates the swift acquisition and real-time analysis of high-quality cardiac and vascular images, empowering clinicians with timely insights at the point of care. With its ability to provide immediate, high-quality imaging, Vscan Air SL assists physicians in making well-informed decisions promptly, thereby enhancing patient care. Its intuitive design streamlines healthcare workflows, enabling quicker and more efficient treatment planning for needy patients. Vscan Air SL alleviates the strain on conventional imaging resources by offering on-the-spot diagnostic capabilities, ensuring that medical professionals can deliver care with greater agility and effectiveness. "Having ever more powerful handheld ultrasound is a game changer for patient care," said Guy Lloyd, M.D., FRCP, Consultant Cardiologist at Barts Heart Center, University College London Hospitals and Clinical Director for Cardiovascular Diagnostics and Investigations. GE HealthCare is at the forefront of innovation, working to elevate healthcare delivery standards. The company's intelligent devices, supported by advanced data analytics and harnessing artificial intelligence, profoundly impact millions, facilitating quicker and more informed clinical decisions for healthcare practitioners. By pushing the boundaries of medical technology and knowledge, the company is leaving an indelible mark on the healthcare industry, propelling it towards a future characterized by heightened precision, advanced digitization, and improved well-being for patients worldwide. GE HealthCare is a leader in precision care that harmonizes innovation with patient-focused technologies to enhance healthcare. Its commitment is directed toward providing integrated solutions that optimize hospital efficiency, elevate clinician effectiveness, refine therapeutic precision, and improve patient well-being. It aspires to make contributions to the healthcare sphere that transcend traditional limitations.

Read More